Cdk5 Phosphorylation of Doublecortin Ser297 Regulates Its Effect on Neuronal Migration

Neuron

Volumn 41, Issue 2, 2004, Pages 215-227

  Tanaka, Teruyuki ^a   Serneo, Finley F ^a   Tseng, Huang Chun ^b   Kulkarni, Ashok B ^c   Tsai, Li Huei ^b   Gleeson, Joseph G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; DOUBLECORTIN; MUTANT PROTEIN; PROTEIN P35; SERINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL MIGRATION; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MICROTUBULE; MICROTUBULE ASSEMBLY; MOUSE; MUTATION; NERVE CELL; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; WESTERN BLOTTING;

EID: 1642452714     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00852-3     Document Type: Article

References (63)

1. Akagi T., Shishido T., Murata K., Hanafusa H. v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc. Natl. Acad. Sci. USA. 97:2000;7290-7295.
2. Bai J., Ramos R.L., Ackman J.B., Thomas A.M., Lee R.V., LoTurco J.J. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat. Neurosci. 6:2003;1277-1283.
3. Bain J., McLauchlan H., Elliott M., Cohen P. The specificities of protein kinase inhibitors. an update Biochem. J. 371:2003;199-204.
4. Bhaskar K., Shareef M.M., Sharma V.M., Shetty A.P., Ramamohan Y., Pant H.C., Raju T.R., Shetty K.T. Co-purification and localization of Munc18-1 (p67) and Cdk5 with neuronal cytoskeletal proteins. Neurochem. Int. 44:2004;35-44.
5. Bix G.J., Clark G.D. Platelet-activating factor receptor stimulation disrupts neuronal migration In vitro. J. Neurosci. 18:1998;307-318.
6. Brady S.T., Tytell M., Lasek R.J. Axonal tubulin and axonal microtubules. biochemical evidence for cold stability J. Cell Biol. 99:1984;1716-1724.
7. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 10:1993;1089-1099.
8. Caspi M., Atlas R., Kantor A., Sapir T., Reiner O. Interaction between LIS1 and doublecortin, two lissencephaly gene products. Hum. Mol. Genet. 9:2000;2205-2213.
9. Chae T., Kwon Y.T., Bronson R., Dikkes P., Li E., Tsai L.H. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron. 18:1997;29-42.
10. Chang L., Jones Y., Ellisman M.H., Goldstein L.S., Karin M. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev. Cell. 4:2003;521-533.
11. Corbo J.C., Deuel T.A., Long J.M., LaPorte P., Tsai E., Wynshaw-Boris A., Walsh C.A. Doublecortin is required in mice for lamination of the hippocampus but not the neocortex. J. Neurosci. 22:2002;7548-7557.
12. Delalle I., Bhide P.G., Caviness V.S. Jr., Tsai L.H. Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse. J. Neurocytol. 26:1997;283-296.
13. Dobyns W.B., Andermann E., Andermann F., Czapansky-Beilman D., Dubeau F., Dulac O., Guerrini R., Hirsch B., Ledbetter D.H., Lee N.S.et al. X-linked malformations of neuronal migration. Neurology. 47:1996;331-339.
14. Ebneth A., Drewes G., Mandelkow E.M., Mandelkow E. Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells. Cell Motil. Cytoskeleton. 44:1999;209-224.
15. Egelhoff T.T., Lee R.J., Spudich J.A. Dictyostelium myosin heavy chain phosphorylation sites regulate myosin filament assembly and localization in vivo. Cell. 75:1993;363-371.
16. Francis F., Koulakoff A., Boucher D., Chafey P., Schaar B., Vinet M.C., Friocourt G., McDonnell N., Reiner O., Kahn A.et al. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron. 23:1999;247-256.
17. Friocourt G., Chafey P., Billuart P., Koulakoff A., Vinet M.C., Schaar B.T., McConnell S.K., Francis F., Chelly J. Doublecortin interacts with mu subunits of clathrin adaptor complexes in the developing nervous system. Mol. Cell. Neurosci. 18:2001;307-319.
18. Gambello M.J., Darling D.L., Yingling J., Tanaka T., Gleeson J.G., Wynshaw-Boris A. Multiple dose-dependent effects of Lis1 on cerebral cortical development. J. Neurosci. 23:2003;1719-1729.
19. Gilmore E.C., Herrup K. Neocortical cell migration. GABAergic neurons and cells in layers I and VI move in a cyclin-dependent kinase 5-independent manner J. Neurosci. 21:2001;9690-9700.
20. Gilmore E.C., Ohshima T., Goffinet A.M., Kulkarni A.B., Herrup K. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J. Neurosci. 18:1998;6370-6377.
21. Glantz, S.A. (1996). Primer of Biostatistics, 4th edition (New York: McGraw-Hill).
22. Gleeson J.G., Walsh C.A. Neuronal migration disorders. from genetic diseases to developmental mechanisms Trends Neurosci. 23:2000;352-359.
23. Gleeson J.G., Lin P.T., Flanagan L.A., Walsh C.A. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron. 23:1999;257-271.
24. Gönczy P., Bellanger J.-M., Kirkham M., Pozniakowski A., Baumer K., Phillips J.B., Hyman A.A. zyg-8, a gene required for spindle positioning in C. elegans, encodes a doublecortin-like kinase. Dev. Cell. 1:2001;363-375.
25. Gupta A., Tsai L.H., Wynshaw-Boris A. Life is a journey. a genetic look at neocortical development Nat. Rev. Genet. 3:2002;342-355.
26. Han G., Liu B., Zhang J., Zuo W., Morris N.R., Xiang X. The Aspergillus cytoplasmic dynein heavy chain and NUDF localize to microtubule ends and affect microtubule dynamics. Curr. Biol. 11:2001;719-724.
27. Hatten M.E. Neuronal regulation of astroglial morphology and proliferation in vitro. J. Cell Biol. 100:1985;384-396.
28. Hirotsune S., Fleck M.W., Gambello M.J., Bix G.J., Chen A., Clark G.D., Ledbetter D.H., McBain C.J., Wynshaw-Boris A. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat. Genet. 19:1998;333-339.
29. Horesh D., Sapir T., Francis F., Wolf S.G., Caspi M., Elbaum M., Chelly J., Reiner O. Doublecortin, a stabilizer of microtubules. Hum. Mol. Genet. 8:1999;1599-1610.
30. Hoshi M., Akiyama T., Shinohara Y., Miyata Y., Ogawara H., Nishida E., Sakai H. Protein-kinase-C-catalyzed phosphorylation of the microtubule-binding domain of microtubule-associated protein 2 inhibits its ability to induce tubulin polymerization. Eur. J. Biochem. 174:1988;225-230.
31. Huang W., Erikson R.L. Constitutive activation of Mek1 by mutation of serine phosphorylation sites. Proc. Natl. Acad. Sci. USA. 91:1994;8960-8963.
32. Huettner J.E., Baughman R.W. Primary culture of identified neurons from the visual cortex of postnatal rats. J. Neurosci. 6:1986;3044-3060.
33. Illenberger S., Drewes G., Trinczek B., Biernat J., Meyer H.E., Olmsted J.B., Mandelkow E.M., Mandelkow E. Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics. J. Biol. Chem. 271:1996;10834-10843.
34. Keshvara L., Magdaleno S., Benhayon D., Curran T. Cyclin-dependent kinase 5 phosphorylates disabled 1 independently of Reelin signaling. J. Neurosci. 22:2002;4869-4877.
35. Kizhatil K., Wu Y.X., Sen A., Bennett V. A new activity of doublecortin in recognition of the phospho-FIGQY tyrosine in the cytoplasmic domain of neurofascin. J. Neurosci. 22:2002;7948-7958.
36. Ko J., Humbert S., Bronson R.T., Takahashi S., Kulkarni A.B., Li E., Tsai L.H. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 21:2001;6758-6771.
37. Leger J., Kempf M., Lee G., Brandt R. Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J. Biol. Chem. 272:1997;8441-8446.
38. Lindwall G., Cole R.D. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J. Biol. Chem. 259:1984;5301-5305.
39. Matsushita M., Matsui H., Itano T., Tomizawa K., Tokuda M., Suwaki H., Wang J.H., Hatase O. Developmental changes of cyclin dependent kinase 5 subcellular localization in the rat cerebellum. Neuroreport. 6:1995;1267-1270.
40. Meijer L., Borgne A., Mulner O., Chong J.P., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., Moulinoux J.P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:1997;527-536.
41. Naviaux R.K., Costanzi E., Haas M., Verma I.M. The pCL vector system. rapid production of helper-free, high-titer, recombinant retroviruses J. Virol. 70:1996;5701-5705.
42. Niethammer M., Smith D.S., Ayala R., Peng J., Ko J., Lee M.S., Morabito M., Tsai L.H. NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron. 28:2000;697-711.
43. Nikolic M., Dudek H., Kwon Y.T., Ramos Y.F., Tsai L.H. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10:1996;816-825.
44. Nikolic M., Chou M.M., Lu W., Mayer B.J., Tsai L.H. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature. 395:1998;194-198.
45. Ohshima T., Ward J.M., Huh C.G., Longenecker G., Veeranna, Pant H.C., Brady R.O., Martin L.J., Kulkarni A.B. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. USA. 93:1996;11173-11178.
46. Ohshima T., Gilmore E.C., Longenecker G., Jacobowitz D.M., Brady R.O., Herrup K., Kulkarni A.B. Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous. J. Neurosci. 19:1999;6017-6026.
47. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 402:1999;615-622.
48. Patzke H., Maddineni U., Ayala R., Morabito M., Volker J., Dikkes P., Ahlijanian M.K., Tsai L.H. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene. J. Neurosci. 23:2003;2769-2778.
49. Sapir T., Horesh D., Caspi M., Atlas R., Burgess H.A., Wolf S.G., Francis F., Chelly J., Elbaum M., Pietrokovski S., Reiner O. Doublecortin mutations cluster in evolutionarily conserved functional domains. Hum. Mol. Genet. 9:2000;703-712.
50. Sasaki S., Shionoya A., Ishida M., Gambello M.J., Yingling J., Wynshaw-Boris A., Hirotsue S. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron. 28:2000;681-696.
51. Schaar B.T., Kinoshita K., McConnell S.K. Doublecortin microtubule affinity is regulated by a balance of kinase and phosphatase activity at the leading edge of migrating neurons. Neuron. 42:2004;203-213. , this issue.
52. Simmons D.M., Voss J.W., Ingraham H.A., Holloway J.M., Broide R.S., Rosenfeld M.G., Swanson L.W. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev. 4:1990;695-711.
53. Songyang Z., Lu K.P., Kwon Y.T., Tsai L.H., Filhol O., Cochet C., Brickey D.A., Soderling T.R., Bartleson C., Graves D.J.et al. A structural basis for substrate specificities of protein Ser/Thr kinases. primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1 Mol. Cell. Biol. 16:1996;6486-6493.
54. Takahashi S., Saito T., Hisanaga S., Pant H.C., Kulkarni A.B. Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules. J. Biol. Chem. 278:2003;10506-10515.
55. Tanaka T., Veeranna, Ohshima T., Rajan P., Amin N.D., Cho A., Sreenath T., Pant H.C., Brady R.O., Kulkarni A.B. Neuronal cyclin-dependent kinase 5 activity is critical for survival. J. Neurosci. 21:2001;550-558.
56. Taylor K.R., Holzer A.K., Bazan J.F., Walsh C.A., Gleeson J.G. Patient mutations in doublecortin define a repeated tubulin-binding domain. J. Biol. Chem. 275:2000;34442-34450.
57. Tomizawa K., Matsui H., Matsushita M., Lew J., Tokuda M., Itano T., Konishi R., Wang J.H., Hatase O. Localization and developmental changes in the neuron-specific cyclin-dependent kinase 5 activator (p35nck5a) in the rat brain. Neuroscience. 74:1996;519-529.
58. Tomoda T., Bhatt R.S., Kuroyanagi H., Shirasawa T., Hatten M.E. A mouse serine/threonine kinase homologous to C. elegans UNC51 functions in parallel fiber formation of cerebellar granule neurons. Neuron. 24:1999;833-846.
59. Tsai L.H., Takahashi T., Caviness V.S. Jr., Harlow E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development. 119:1993;1029-1040.
60. Vallee, R.B. (1986). Reversible assembly purification of microtubules without assembly-promoting agents and further purification of tubulin, microtubule-associated proteins, and MAP fragments. In Methods Enzymol., pp. 89-104.
61. Yeh E., Yang C., Chin E., Maddox P., Salmon E.D., Lew D.J., Bloom K. Dynamic positioning of mitotic spindles in yeast. role of microtubule motors and cortical determinants Mol. Biol. Cell. 11:2000;3949-3961.
62. Zaharevitz D.W., Gussio R., Leost M., Senderowicz A.M., Lahusen T., Kunick C., Meijer L., Sausville E.A. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. Cancer Res. 59:1999;2566-2569.
63. Zaman K., Ryu H., Hall D., O'Donovan K., Lin K.I., Miller M.P., Marquis J.C., Baraban J.M., Semenza G.L., Ratan R.R. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J. Neurosci. 19:1999;9821-9830.